3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
1
Interventions
rindopepimut
1
pembrolizumab
1
mogamulizumab
1
gallium maltolate
1
efineptakin alfa
1
Ipilimumab
1
Cancer Vaccines
1
Adjuvants, Immunologic
1
ABT-414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
No longer available
×
Glioblastoma
×
mogamulizumab
×
Clear all
NCT04321694
2024-04-25
Expanded Access for KHK2455
Kyowa Kirin Co., Ltd.
No longer available